Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 Diabetes

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2016 by AstraZeneca
Sponsor:
Information provided by (Responsible Party):
AstraZeneca
ClinicalTrials.gov Identifier:
NCT01554618
First received: March 13, 2012
Last updated: November 23, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2023
  Estimated Primary Completion Date: June 2020 (Final data collection date for primary outcome measure)